Template:Cilostazol: Difference between revisions

Latest revision as of 21:49, 28 February 2014

Cilostazol
PLETAL^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Studies
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages

@@ Line 21: / Line 21: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Cilostazol description|Description]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Cilostazol clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Cilostazol clinical pharmacology|Clinical Pharmacology]]